Sorry, but nothing matched your search terms. Please try again with some different keywords.
Nothing Found
- Move over, GLP-1s. Syntis launches with clinical-stage obesity pill to mimic gastric bypass surgery
- Thousands of children got tested for lead with faulty devices: What parents should know
- Abbott claims FDA clearances for pair of over-the-counter diabetes trackers
- Skye Bioscience ends eye disease R&D efforts after glaucoma drug’s phase 2 fail
- Oculis sees promise in dry eye disease subgroup, plans phase 3
- Lilly’s donanemab sails through FDA meeting with 2 unanimous votes in favor
- Urinary incontinence neuromod newcomer Amber Therapeutics nets $100M
- Alumis sets out IPO ambitions to fund TYK2 inhibitor through phase 3 psoriasis trials
- Weekly Market Review – September 21, 2024
- Weekly Market Review – September 14, 2024